- $1.20tn
- $1.24tn
- $65.18bn
GLP-1 boom in China, India, Brazil could create $22 bln market by 2035, J.P. Morgan says
Weight-loss drugs fuel protein boom, but with more consumer scrutiny
Graphic: Take Five: AI trade meets the Fed
Corrected: Health Rounds: New US hepatitis B vaccine guidelines likely leave many infants vulnerable
US RESEARCH ROUNDUP-Eli Lilly, Netflix, Zscaler
Focus: Beauty giants target 'Ozempic face' as boom in obesity drugs opens new market
US STOCKS ON THE MOVE-Hilton, MSCI, Tradeweb, Eli Lilly
US STOCKS ON THE MOVE-Hilton, MSCI, Tradeweb, Eli Lilly
Eli Lilly hits record high as healthcare stocks rally
Novo's CagriSema helped women lose 25% of weight on average, analysis shows
HK-listed Metis TechBio climbs on deal with Eli Lilly
Factbox: Major drugmakers turn to China for licensing deals
HK-listed Metis TechBio, Eli Lilly strike drug-delivery deal worth up to $1.1 billion (updated)
Metis TechBio inks up to $1.1 billion deal with Eli Lilly for drug delivery tech
Brief: Metis Techbio Enters Strategic Collaboration With Lilly
Focus: Cherry or tabasco? Perfumers test weight-loss drug users' appetite for food-inspired scents
Factbox: Weight-loss drug developers line up to tap lucrative market as competition heats up
Eli Lilly's weight-loss pill wins EU drug regulator's backing (updated)
Canada Stocks: TSX rises, touches three-week high